# TargetRx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/targetrx

- Industry: Biotechnology
- Headquarters: Horsham, US
- Website: www.targetrx.com
- Total disclosed funding: $27M
- Latest round: Series D (Apr 22, 2005)
- Investors on record: 6

## About

TargetRx, Inc. provides pharmaceutical and biotech enterprises with insight into the drivers of prescribing.

## Funding rounds

- Series D, Apr 22, 2005, $15M — Domain Associates, New Enterprise Associates, Quaker Partners Management, Acacia Venture Partners, Greenspring Associates, Wasatch Global Investors
- Series B, Feb 1, 2005, $12M — Domain Associates, New Enterprise Associates

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B, Series D
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series B, Series D
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series D
- Acacia Venture Partners (https://capitalatlas.ai/funds/acacia-venture-partners) — Series D
- Greenspring Associates (https://capitalatlas.ai/funds/greenspring-associates) — Series D
- Wasatch Global Investors — Series D